CHARACTERIZATION OF ANTIARRHYTHMIC DRUG BINDING SITES IN VOLTAGE GATED CHANNELS
电压门控通道中抗心律失常药物结合位点的表征
基本信息
- 批准号:6242338
- 负责人:
- 金额:$ 24.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-01 至 1997-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Voltage-gated channels are not only essential to countless physiological
functions in heart, but also serve as the molecular target of diverse
anti-arrhythmic agents. With the recent cloning, sequencing, and
expression of voltage-gated Na and K channels, the stage is now set to
identify the key amino acid residues primarily involved in anti-
arrhythmic action on voltage-gated Na and K channels. In particular,
wild-type and mutant versions of both a voltage-gated Na channel derived
from adult skeletal muscle (mu1, Trimmer et al., 1990), as well as a
voltage-gated K channel derived from human heart (HK1, or Kv1.4, Tamkun
et al., 1991) will be expressed in a mammalian cell line and probed by
patch-clamp methods to detect functional changes in the effects of
internally applied QX-314 (for mu1) and clofilium (for HK1), permanently
charged versions of anti-arrhythmic agents. Mutations will be made
according to recent work localizing the probable site of action of
internally active anti-arrhythmic agents to the cytoplasmic vestibule of
Na and K channels (Gingrich et al., 1993; Backx et al., 1992, Choi et
al., 1993). Unmasking the arrangement of amino acids that are important
for drug action would be a crucial prerequisite to unravelling the
mechanism of anti-arrhythmic action at the molecular level. Such
understanding would be invaluable in rational drug therapy and design.
电压门控通道不仅对无数生理
在心脏的功能,也是作为分子靶点的多种
抗心律失常药。最近的克隆、测序和
电压门控Na和K通道的表达,现在阶段设置为
确定主要参与抗病毒作用的关键氨基酸残基
电压门控性钠、钾通道的心律失常作用。特别是,
电压门控钠通道的野生型和突变型
来自成人骨骼肌(MU1,Trimmer等人,1990),以及
来自人心脏的电压门控K通道(HK1或Kv1.4,Tamkun
等人,1991)将在哺乳动物细胞系中表达,并通过
膜片钳方法检测大鼠脑缺血后功能改变的影响
内部使用QX-314(用于MU1)和Clofilium(用于HK1),永久
荷电版本的抗心律失常药。突变将会发生
根据最近的工作,本地化可能的行动地点
内源性抗心律失常药对前庭细胞的作用
Na和K通道(Gingrich等人,1993;Backx等人,1992,Choi等人
Al.,1993)。揭开重要氨基酸的排列
因为毒品行动将是解开
抗心律失常作用的分子水平机制。是这样的
了解这一点在合理的药物治疗和设计中将是无价的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID T YUE其他文献
DAVID T YUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID T YUE', 18)}}的其他基金
Chemical biological dissection of Ca2+ entry through Ca2+ channels
Ca2+通过Ca2+通道进入的化学生物学解剖
- 批准号:
8609908 - 财政年份:2013
- 资助金额:
$ 24.57万 - 项目类别:
相似海外基金
Establishment of aminoacid transporter directed prostate cancer therapy based on the liquid biopsy
基于液体活检的氨基酸转运蛋白定向前列腺癌治疗的建立
- 批准号:
20K09555 - 财政年份:2020
- 资助金额:
$ 24.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Destribution of vesicular aminoacid transporters during postnatal development in the trigeminal neurons
三叉神经元出生后发育过程中囊泡氨基酸转运蛋白的分布
- 批准号:
24592762 - 财政年份:2012
- 资助金额:
$ 24.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dopaminergic regulation by D-aminoacid oxidase, an enzyme implicated in schizophrenia
D-氨基酸氧化酶(一种与精神分裂症有关的酶)对多巴胺能的调节
- 批准号:
G0801352/1 - 财政年份:2009
- 资助金额:
$ 24.57万 - 项目类别:
Research Grant
Diseases Of Aminoacid Transport: Genetic, Molecular and Biochemical Studies
氨基酸运输疾病:遗传、分子和生化研究
- 批准号:
nhmrc : 402730 - 财政年份:2006
- 资助金额:
$ 24.57万 - 项目类别:
NHMRC Project Grants
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6656505 - 财政年份:2002
- 资助金额:
$ 24.57万 - 项目类别:
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6659279 - 财政年份:2002
- 资助金额:
$ 24.57万 - 项目类别:
L-Aminoacid oxidase, biochemical mechanisms and apoptose induction
L-氨基酸氧化酶、生化机制和细胞凋亡诱导
- 批准号:
5368381 - 财政年份:2002
- 资助金额:
$ 24.57万 - 项目类别:
Research Grants
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6504097 - 财政年份:2001
- 资助金额:
$ 24.57万 - 项目类别:
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6502534 - 财政年份:2001
- 资助金额:
$ 24.57万 - 项目类别: